ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.

Autres langues Zhejiang Hisoar Pharmaceutical Co., Ltd.

Actions

002099

CNE000001PY2

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
5,03 ^CNY	-1,57%		-0,40%	-30,04%

28/04	Zhejiang Hisoar Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
02/02	Zhejiang Hisoar Pharmaceutical Co, Ltd (SZSE:002099) annonce un rachat d'actions pour une valeur de 30 millions CNY. (SZSE:002099) annonce un rachat d'actions pour une valeur de 30 millions CNY.	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	06/05
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 3, 2024, has closed with 31,478,531 shares, representing 1.95% for CNY 151.42 million.	01/05
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Hisoar Pharma's Unit Passes German Health Regulator's Inspection	18/04
Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	01/04
Zhejiang Hisoar Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares.	02/02
Hisoar Pharma Chairman Plans Up to 20 Million Yuan Investment	02/02
Zhejiang Hisoar Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	02/02
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Zhejiang Hisoar Pharma Passes Good Manufacturing Practice Compliance Inspection	22/09/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Zhejiang Hisoar Pharma Registers New Drug For Diabetes Patients	11/07/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 24 May 2023	19/05/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Approves the Profit Distribution Proposal for 2022	16/05/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for 2022	25/04/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/04/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Elects Tao Hong as Non-Independent Director; and Yu Yongping, Qian Jianmin and Liang Chao as Independent Directors	01/12/22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zhejiang Hisoar Pharmaceutical Co., Ltd.

Actions

002099

CNE000001PY2

Autres langues

Filtres